A case of telangiectasis of the uterus: uncontrolled massive uterine bleeding after gnrh agonist therapy.
- Author:
Mi La KIM
1
;
Joo Myung KIM
;
Won Sik LEE
;
Kwan Young JOO
;
In Kook LEE
;
Hye Sun KIM
;
Sung Ran HONG
Author Information
1. Department of Obstetrics and Gynecology, Cheil General Hospital and Women's Healthcare Center, Kwandong University College of Medicine, Seoul, Korea. pil0325@hotmail.com
- Publication Type:Case Report
- Keywords:
Telangiectasis;
Uterus;
Uterine bleeding;
GnRH agonist
- MeSH:
Animals;
Atrophy;
Down-Regulation;
Emergencies;
Endometrium;
Female;
Gonadotropin-Releasing Hormone;
Humans;
Hysterectomy;
Mice;
Myometrium;
Telangiectasis;
Uterine Hemorrhage;
Uterus
- From:Korean Journal of Obstetrics and Gynecology
2008;51(1):100-103
- CountryRepublic of Korea
- Language:Korean
-
Abstract:
Telangiectasis of the uterus is an extremely rare but life-threatening disease because of massive uterine bleeding. The usage of GnRH agonist can cause regression and atrophy of the endometrium through induction of hypoestrogenism by pituitary down-regulation. But there is no clear explanation or report in the literature showing the relationship between uterine telangiectasis and GnRH agonist usage. We have experienced a patient with uncontrolled massive uterine bleeding after GnRH agonist treatment, who needed emergency hysterectomy. Pathologic tissue examination showed telangiectasis of the endometrium and myometrium. This is the first case report of telagiectasis of the uterus without other organ involvement. We report this case with a brief review of the literatures.
